Here we describe the use of data-independent acquisition (DIa) on a Q-exactive mass spectrometer for the detection and quantification of peptides in complex mixtures using the skyline targeted proteomics environment (freely available online at http://skyline.maccosslab.org). the systematic acquisition of mass spectrometry (Ms) or tandem Ms (Ms/Ms) spectra by DIa is in contrast to DDa, in which the acquired Ms/Ms spectra are only suitable for the identification of a stochastically sampled set of peptides. similarly to selected reaction monitoring (srM), peptides can be quantified from DIa data using targeted chromatogram extraction. unlike srM, data acquisition is not constrained to a predetermined set of target peptides. In this protocol, a spectral library is generated using data-dependent acquisition (DDa), and chromatograms are extracted from the DIa data for all peptides in the library. as in srM, quantification using DIa data is based on the area under the curve of extracted Ms/Ms chromatograms. In addition, a quality control (Qc) method suitable for DIa based on targeted Ms/Ms acquisition is detailed. not including time spent acquiring data, and time for database searching, the procedure takes ~1-2 h to complete. typically, data acquisition requires roughly 1-4 h per sample, and a database search will take 0.5-2 h to complete.
IntroDuctIon

DIA 1,2 is a relatively new MS-based technique for systematically collecting MS/MS data
. A data set acquired by DIA has been described as a 'molecular snapshot' of the sample 4 , because the data can be queried for any detectable peptide. Both the presence of a peptide and changes in peptide abundance across samples can be monitored 2 . Therefore, DIA is well-suited for applications in which a researcher needs to measure hundreds of proteins (or more), or for those in which a researcher desires the flexibility to investigate multiple hypotheses without having to acquire additional data sets. This protocol describes how to acquire and analyze MS data using DIA for the analysis of peptides.
Method setup for DIA is simpler when compared with targeted acquisition approaches such as SRM or parallel reaction monitoring (PRM), which require complex scheduling to measure beyond ~50 peptides [5] [6] [7] .
DIA has been used almost exclusively in 'bottom-up' MS analyses in which proteins are digested into peptides using a proteolytic enzyme (e.g., trypsin) before analysis 8 . In contrast to intact proteins, the resulting peptides have reduced physiochemical diversity, resulting in simplified sample preparation and increased mass spectrometric sensitivity 9 . After digestion, peptides are separated by reversed-phase HPLC and emitted directly into a mass spectrometer via an electrospray ionization (ESI) interface 10 . On trapping instruments (such as the Q-Exactive), ions transmitted into the mass spectrometer are collected over a short period (often <100 ms) and analyzed by MS/MS (ref. 11 ). An MS spectrum consists of the mass-to-charge ratios (m/z) and signal intensity (charges/second) of the collected intact peptide ions. An MS/MS spectrum consists of m/z versus intensity of fragment ions derived from peptide precursors that had been isolated by m/z before fragmentation using collisions with an inert gas (Fig. 1) . In complex samples (e.g., mammalian), quantification using the MS/MS signal is generally more sensitive than using the MS signal alone owing to increased selectivity 2,4,12, 13 . In complex samples, there is a greater likelihood that an MS signal for a peptide will have interference in the form of chemical noise from another analyte in the sample with the same m/z (e.g., a peptide with the same amino acid composition but different sequence) or a very close m/z that cannot be resolved by the mass analyzer. In these cases, quantification using the MS/MS signal will be more sensitive because the more selective fragment ion measurements will be less prone to chemical noise interference. For low complexity samples (e.g., simple prokaryotes, selectively enriched samples), accurate mass measurement of intact peptide mass, combined with chromatographic retention time, can be sufficiently selective for quantitative measurements 14 . However, for larger proteomes (e.g., mammalian), selective quantification requires the additional measurement of peptide fragment ions.
There are many possible strategies for collecting DIA data 3 . The DIA technique detailed here provides a starting point that is suitable for many applications. This method acquires both MS and MS/MS data for all molecular species between m/z 500 and 900. The mass spectrometer is programmed to acquire a repeated cycle of 20 MS/MS scans with contiguous isolation windows, each being 20 m/z wide. The first MS/MS spectrum contains fragments derived from peptide precursor ions isolated from the range from m/z 500-520, the next contains fragments from the m/z range of 520-540 and so on until the twentieth MS/MS scan, which analyzes fragments in the m/z range of 880-900 (Fig. 1 ). An MS scan is acquired every tenth MS/MS scan. On a Q-Exactive instrument, this cycle repeats every ~2 s, which is fast enough to perform analysis of peptides on a chromatographic time scale.
To detect and quantify a peptide, mass chromatograms (m/zspecific signal intensity over time) are extracted for a set of probable precursor charge states (e.g., +2, +3 and +4 for tryptic peptides) and their associated fragment ions 2, 4, 15 . This targeted chromatogram extraction produces data that can be analyzed in fundamentally the same way as SRM data. However, DIA data acquisition differs from SRM because the precursor isolation window for MS/MS scans is much wider and does not target any specific precursor. In this way, DIA combines untargeted data acquisition with targeted data analysis 4 . The quantitative metric for each peptide is calculated using the background-subtracted area under the curve of the precursor or fragment ion chromatograms over the peptide elution. Changes in these peak areas can be statistically evaluated using packages such as MSStats 16 , which is used in conjunction with Skyline 17 , to determine which of a set of assayed peptides have a statistically significant increase or decrease in abundance between samples.
It is useful, although not strictly necessary, to have prior knowledge of when a peptide elutes from the chromatography column (i.e., retention time) to detect and quantify the peptide using DIA data 1, 18 . In this regard, having a spectral library can aid in the analysis of DIA data because it contains retention time information and reference MS/MS spectra for each peptide. In this protocol, a spectral library is generated from DDA data acquired on each type of biological sample to aid in the interpretation of DIA data. However, pre-existing spectral libraries can also be used.
The Skyline software platform aids in both the acquisition and interpretation of data in this protocol. Skyline is a familiar tool to many for the generation of instrument methods for SRM data acquisition and interpretation of the resulting data. However, it is also capable of interpreting DIA data in a similar manner to that used for SRM. Because both SRM and DIA data are based on the analysis of MS/MS chromatograms (selected and extracted respectively), the processing (chromatogram peak integration) and visualization of data acquired using these two methods is very similar within Skyline (Fig. 1) . Therefore, the DIA workflow described in this protocol should be familiar to those with experience using Skyline for SRM. This familiarity, combined with the availability (free and open source), vendorneutrality, extensive documentation and active support of Skyline, makes it an attractive option for processing DIA data. There are other software platforms (e.g., ABSciex PeakView, Biognosys Spectronaut, OpenSWATH 19 , Thermo Pinpoint and Waters Protein Lynx Global Server) that support the interpretation of DIA data, although only a subset of these platforms can currently analyze the data acquired using the technique in this protocol (OpenSWATH and Pinpoint).
Experimental design
There is no 'one size fits all' DIA method. Some key considerations in designing an optimal DIA method are sample complexity, chromatography conditions, the mass spectrometer being used and the desired sensitivity. The method presented in this protocol is a recommended starting point for analysis of a complex sample (yeast lysate) on a Q-Exactive using HPLC-MS/MS. However, there are many parameters of a DIA method that may need to be adjusted depending on the experiment. Some of the key performance characteristics of a DIA method are described below.
MS/MS isolation width.
The MS/MS isolation width alters the precursor selectivity of the method. With wide isolation windows, precursor selectivity is low, many precursors are co-fragmented and highly chimeric MS/MS spectra are generated 20 . These highly chimeric spectra have increased chemical noise, which compromises the sensitivity of the method. The more complex a sample is, the more the sensitivity will be improved by reducing the MS/MS isolation width 12 . This protocol uses an isolation width of 20 m/z. This width should be increased if the sample is of low complexity, if a larger m/z range needs to be analyzed or if the better sampling of each chromatographic peak is required (Table 1) , and it should be decreased if greater sensitivity is required.
Chromatographic sampling rate. The sampling rate is often referred to as the 'duty cycle' of the method; in the context of DIA, Figure 1 | MS/MS analysis in data-dependent acquisition and data-independent acquisition. DDA acquires MS/MS scans with narrow isolation windows centered on peptide precursors detected in an MS scan. DIA acquires MS/MS scans with wide isolation windows that do not target any particular peptide precursor. Instead, the scans are arranged side-by-side to collectively cover a desired precursor m/z range (500-900 m/z here) comprehensively. Fragment ion information for the peptide precursor VLENTEIGDSIFDK++ is present in a single MS/MS spectrum in a DDA analysis, but it can be extracted over time from DIA data and used for quantification owing to the repetitive MS/MS sampling cycle of DIA.
we define the chromatographic sampling rate as how frequently over time a particular precursor will be sampled by MS or MS/MS as it elutes. To accurately measure the signal for a precursor, at least eight (and preferably >10) measurements must be made as the precursor elutes 21 . Therefore, if the average width of a chromatographic peak is ~30 s, the duty cycle must be 3 s or less to measure ten points across each peak. In this protocol, each precursor is sampled every 2 s by MS/MS and every second by MS. m/z range covered. This is the range of precursor m/z that is analyzed by MS/MS in the experiment. In this protocol, the m/z range covered is 500-900 m/z, because this region is very peptidedense in a tryptic digest 22 . This region is roughly two times as peptide-dense as the rest of the m/z range 23 . However, there are still peptides that will fall outside of this range that would require an expanded m/z range to cover. The m/z range may need to be reduced or expanded, depending on the scan speed and ion optics 23 of the mass spectrometer used, the desired assay sensitivity and/or the required chromatographic sampling rate ( Table 1) .
Resolving power. The resolving power is the ability of the mass analyzer to resolve two nearby peaks. High resolving power can improve quantification by resolving nearby interfering MS or MS/MS peaks from the desired signal peak 24 . On low-resolving-power mass analyzers, such as a linear ion trap, it may be necessary to decrease the MS/MS isolation width (increase precursor selectivity) to measure peptides in a complex sample 12, 20 . In addition, on Fourier-transform (FT-ion cyclotron resonance (ICR), Orbitrap) and ion trap mass analyzers 25 , the resolving power affects the spectrum acquisition rate (higher resolving power reduces spectrum acquisition rate). On Fourier-transform mass analyzers, this is due to a longer transient acquisition required for higher resolving power. On ion-trap instruments, this is due to a slower scan speed (kDa/s) required for higher resolving power. In this protocol, the resolving power is set to 17,500 at 200 m/z for the MS/MS scans, and 35,000 at 200 m/z for MS scans.
Mass accuracy.
Mass measurement accuracy is a metric for how close a measured m/z is to its theoretical value. High mass measurement accuracy increases confidence that the signal measured is qualitatively the correct target peptide of interest 24, [26] [27] [28] .
AGC target and maximum ion injection time. These parameters apply to ion-trapping instruments only. The AGC target is the target number of charges placed in the trap for an MS or MS/MS scan. It is preferable to 'fill' the trap to its maximum capacity (limited by space-charging effects) to achieve the greatest sensitivity and dynamic range. However, it is also necessary to impose a maximum inject time-the maximum amount of time spent filling the trap in an attempt to reach the AGC target-to maintain the required scan rate. In this protocol, the AGC target for MS and MS/MS scans is set to 1,000,000 ions, and the maximum injection time is set to 55 ms for MS and 'auto' for MS/MS scans, respectively (Supplementary Note).
Number of sample injections. In this protocol, the analysis is completed in a single sample injection. However, if multiple sample injections (i.e., multiple liquid chromatography (LC) runs) are used for each sample, selectivity can be improved by reducing the MS/MS isolation width, or the m/z range covered can be increased.
The DIA method described in this protocol can be altered to improve sensitivity, to cover more peptides or to increase the chromatogram sampling rate ( Table 1 ). The protocol is not specific to any particular LC setup. However, it is optimal for an HPLC separation that generates peaks with an average full-width at half-maximum (FWHM) of ~15 s. If the peak width is expected to be much different, the protocol should be modified 
Improve chromatogram sampling
Increase the isolation width ↓ ↑
Reduce the m/z range covered ↓ ↑ (Table 1) . Similarly, the protocol is not specific to a particular QC standard. However, if too many QC peptides are analyzed in a single method, the chromatographic sampling rate may suffer. The QC sample and HPLC setup used to generate example data (see ANTICIPATED RESULTS section) are described in the Supplementary Methods. Because Skyline is a vendor-neutral platform, it can be used to generate DIA methods and to analyze data for almost any DIAcapable mass spectrometer. However, the optimal parameters for the DIA method will vary depending on the scan rate, resolving power, dynamic range and sensitivity of the mass analyzer.
To generate a spectral library, DDA data are acquired on each type of sample. Not all samples need to be analyzed in the generation of the spectral library. However, the diversity of samples analyzed should be represented in the set of samples chosen for a spectral library so that each potential protein of interest is present in at least one of the samples included in the library. The DDA parameters used in this protocol may not be optimal, depending on the type of sample used and chromatography conditions. Optimization of DDA parameters for the analysis of complex samples on a Q-Exactive is a topic that has been explored previously 29 , and it is outside the scope of this manuscript. SEQUEST 30 is used for database searching combined with Percolator 31 to calculate the statistical significance of peptide-spectrum matches. However, there are many other database search pipelines that are supported by Skyline, and they can be used in lieu of SEQUEST and Percolator. The tools that are currently supported are PeptideProphet, SpectrumMill, OMSSA, PEAKS DB, Morpheus, X!Tandem, Mascot, Protein Pilot, ID Picker (Myrimatch), PRIDE, MaxQuant, Proteome Discoverer, Scaffold, ByOnic, MSGF+ and ProteinLynx Global Server. More information can be found at http://proteome.gs.washington.edu/software/bibliospec.
Comparison with other methods
The performance of the DIA technique presented in this protocol is difficult to compare with the performance of other DIA techniques, because the performance of any method is dependent on the sample being analyzed and LC conditions. However, these techniques can be compared on the basis the key metrics presented in the Experimental design section. 
SWATH. The technique presented in this protocol is most similar to the SWATH
MS E . The original MS E technique alternates between
'high-energy' and 'low-energy' scans on a Q-TOF instrument 1, 33 . The high-energy scans are MS/MS scans with no precursor isolation, and the low-energy scans are MS scans. MS E has a much lower precursor selectivity than the method in this protocol, but it has a much faster duty cycle (~0.3 s), which makes the technique compatible with ultra-performance LC. Modern implementations of MS E use ion-mobility separation before peptide fragmentation to improve precursor selectivity 34 .
Selected reaction monitoring.
Rather than broadly interrogating a wide precursor m/z range, SRM 35, 36 acquires MS/MS data on a preselected set of hundreds of peptide precursor targets (assuming prior knowledge of retention time) 6, 7 . Both the acquisition and analysis of SRM data are targeted, whereas for DIA data only analysis is targeted. Owing to the targeted acquisition of SRM data, the acquired data are informative only for the preselected targets. DIA data are unhindered by this constraint because the data can be queried for any peptide in a wide m/z range. Therefore, if a large number of peptides need to be analyzed (e.g., interrogation of large signaling pathways or classes of proteins), or the peptides that need to be analyzed may change in the course of data analysis (e.g., iterative hypothesis testing), DIA is the preferred method. However, if an investigator is only interested in a restricted set of peptides, SRM is expected to provide more accurate and sensitive measurements than the DIA protocol presented here 37 .
The DIA method in this protocol uses much wider isolation windows (20 m/z) than is typical for SRM (0.2-1 m/z). Because of the greater isolation window width, the majority of DIA spectra will be chimeric, which can potentially lead to more interference in the chromatograms extracted from DIA data than SRM. However, the higher resolving power of the Orbitrap mass analyzer (17,500 at 200 m/z) relative to the quadrupole mass filter typically used for SRM (~200-1,000 at 200 m/z) recovers some of the selectivity lost in the precursor isolation 4,37 relative to SRM. In both SRM and DIA, peptides can be quantified in spite of chimeric spectra (DIA) or coisolation (SRM) so long as there are transitions that are selective for the peptide of interest with enough signal for quantification 4, 6 .
Data-dependent acquisition. In DDA 38 , MS/MS scans are acquired on a subset of precursors detected in an MS 'survey' scan. DDA cycles between acquisition of an MS survey scan and acquisition of MS/MS scans targeting the top N precursors detected in the most recent survey scan. Because the MS/MS scans have a narrow isolation width (usually ~2 m/z) centered on a detected precursor, they are less chimeric than DIA spectra and are more amenable to database searching to assign a peptide sequence to each spectrum. Quantification can be performed by integrating precursor ion chromatograms extracted from the MS signal, spectral counting or measuring MS/MS reporter ions from samples with isobarically tagged peptides 39 . However, quantification by extracted fragment ion chromatograms as in SRM and DIA analysis is not possible owing to incomplete and irregular sampling of chromatographic peaks by MS/MS (Fig. 1) . This caveat limits quantification in complex mixtures in which integration of fragment ion chromatograms is more selective and therefore more sensitive than MS-based quantification 40 .
DDA is a powerful technique for the identification of peptides in a sample, but it is less effective for the detection of any particular peptide of interest. To detect a peptide, the MS/MS data must be queried for the signal specific to that peptide. Because the MS/MS data in a DDA experiment are sampled stochastically, it is impossible to determine whether a peptide with no matching spectra is nondetectable, or detectable but not sampled by MS/MS.
Limitations
As with any MS-based technique, many peptides will fall below the limit of detection of DIA. It may be necessary to enrich the sample for the proteins or peptides of interest before analysis, or to use fractionation techniques to improve sensitivity further. Even then, many peptides and proteins may still remain below the limit of detection 41 .
It is possible 1,2,15,18,42,43 but challenging to detect peptides directly from DIA data without the aid of a spectral library or a retention time calibration standard. When fragment ion chromatograms have been extracted for a peptide precursor, there are often multiple potential peaks in retention time where fragment ions co-elute, making it difficult to select the correct peak for the peptide 13 . In addition, it is difficult to assign statistical confidence in the detection of a peptide once the correct peak has been selected. For these reasons, this protocol includes a step to generate a spectral library using DDA combined with a database search. The spectral library is a set of MS/MS spectra that have been confidently matched to a peptide sequence using an automated database search algorithm. The spectral library contains information about the expected retention time of the peptide and the expected fragment ion intensity ratios, which aid in selection of the correct peak for a peptide.
Unfortunately, the set of peptides that can be analyzed in the DIA data using this protocol is limited to those that are present in the spectral library (identified by DDA). A similar technique to counter this limitation is to generate a single, deep spectral library for an organism using extensive sample fractionation and to use that library for all future DIA analyses of that organism 44 .
The collision energy used for peptide fragmentation can be optimized on the basis of the charge state of a selected precursor in DDA and SRM experiments 45, 46 . In DIA experiments, the collision energy cannot be optimized by charge state because many precursors are co-fragmented without any particular precursor being the target for MS/MS analysis. In this protocol, the collision energy is optimized for a precursor charge state of +2 ('Default charge state' setting in Xcalibur method editor). Peptides with other charge states may not fragment as well and high-m/z fragment ions from peptides with charge states greater than +2 may not be measured. 47 is used to monitor the performance of the LC setup and mass spectrometer throughout an experiment. The sample is analyzed by LC-MS/MS 3-5 times at the beginning of the experiment to establish a baseline. After this, the sample is analyzed roughly every five LC runs and compared with the baseline to detect any issues that may arise, such as spray instability, excessive retention time or peak area variability, irregularities in chromatographic peak shape, contaminants, excessive sample carry-over, a reduction in mass measurement accuracy or poor peptide fragmentation. The QC sample should be a mixture containing at least six, but preferably ten, known peptides with elution times spread across the entire separation gradient and a strong signal in both MS and MS/MS scans. A complex sample such as yeast lysate may be used, or a simpler
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mixture containing a set of synthetic peptides is also appropriate. Preferably, the QC sample should be easy to prepare reproducibly in large quantities that can be frozen as single-use aliquots. QC sample preparation Solubilize BSA in 50 mM ammonium bicarbonate buffer and quantify using the BCA protein assay. Dry and resolubilize 200 µg in 50 µl of 8 M urea containing 200 mM ammonium bicarbonate. Reduce the disulfides using 10 mM tris(2-carboxyethyl)phosphine for 1 h at room temperature and then alkylate using 11 mM iodoacetamide for 20 min, also at room temperature (21 °C). Add 150 µl of water to dilute the urea to 2 M, and then add Promega trypsin at a substrate-to-enzyme ratio of 50:1 and digest it overnight at 37 °C. Stop the digestion by adding trifluoroacetic acid, and then desalt using an MCX cartridge. Dry the desalted digest using vacuum centrifugation, and combine the resolubilized BSA tryptic peptides (200 fmol/µl) with 50 fmol/µl peptide retention time calibration standard. The QC sample can be stored indefinitely at -80 °C. Note that the preparation of the QC sample used for demonstration in the ANTICIPATED RESULTS section is slightly different-four additional bovine proteins are included-and it is described in Supplementary Methods. Protein digests for analysis by DIA and/or DDA These are the biological samples that will be used to test a hypothesis on the basis of the detection and quantification of peptides in the samples. Sample preparation is the same for DDA and DIA analysis, but in most cases only a subset of the samples will be analyzed by DDA (see Experimental design in the INTRODUCTION). This protocol assumes that the samples were digested with trypsin, and are MS compatible (free or minimal amount of detergents, salts, metabolites, lipids, nucleic acids, sugars and other contaminants). The preparation of a yeast tryptic digest used for demonstration in the ANTICIPATED RESULTS section is described in Supplementary Methods. 7| Click the 'Full Scan' tab, populate the fields in this window to match those in Figure 2 and click 'OK' .
8|
Add the peptides in the QC mixture to the document by clicking 'Edit' → 'Insert' → 'Peptides', by entering the QC peptides to be analyzed into the window and then clicking 'Insert' .
9| (Optional, Steps 9-11) Refining precursors for QC samples with isotope modifications.
If peptides with isotope modifications are being analyzed, Click 'Edit' → 'Expand All'→ 'Peptides' .
10|
Hold down the Ctrl key and select all of the 'light' peptide precursors in the Targets pane of the main Skyline window for peptides that have isotope modifications, but for which you do not wish to measure the unmodified analyte (Fig. 3) . Press the Delete key to remove them.
11|
Hold down the Ctrl key and select all of the 'heavy' peptide precursors in the 'Targets' pane of the main Skyline window for peptides that do not have isotope modifications. Press the Delete key to remove them. 15| Populate the 'Method Duration' and 'Chromatographic Peak Width (FWHM)' fields to match the chromatography method being used (Fig. 4, top) .
16| Drag and drop a 'Full MS-SIM' scan event from under the 'Experiments' heading to the timeline.
17| Set the properties of the 'Full MS' scan to match those in Figure 4 (bottom left).
18|
Drag and drop N 'Targeted-MS 2 ' scans from under the 'Experiments' heading to the timeline, where N is the number of QC peptides being analyzed.
19|
Edit the runtime of all scan events in the method by holding down the Ctrl key, selecting each scan under the 'Scan Groups' heading, releasing the Ctrl key and entering the 'Runtime' to match the full method duration.
20|
Select all of the 'targeted-MS 2 ' scans and set the properties to match Figure 4 (bottom right).
21|
Click on 'Global Lists' heading and select 'Inclusion' . Select 'File' → 'Import' and import the isolation list exported from Skyline in Step 13 (Fig. 5) .
22| Click on the 'Tune Files' heading and select a 'Base Tune File' to be used in the 'Properties' pane. 
23| Enter settings for a LC method (not covered in this protocol).
27|
If chromatography is expected to drift by more than ±2 min, change the 'Use only scans within XX minutes' setting to reflect this.
28|
In the drop-down box under 'Isolation scheme', select '<Add…>' 29| Enter the name '20mzDIA', select 'Prespecified isolation windows' and click the 'Calculate…' button. 40| Set the properties of the DIA scan to match those in Figure 7 (set 'Runtime' to match the 'Method duration').
41|
Click on 'Global Lists' heading and select 'Inclusion' . Select 'File' → 'Import' and import the isolation list exported from Skyline in Step 33.
42|
Click on the 'Tune Files' heading and select a 'Base Tune File' to be used in the 'Properties' pane.
43|
Enter settings for a LC method (not covered in this protocol). 49| Click on the 'Tune Files' heading and select a 'Base Tune File' to be used in the 'Properties' pane.
50| Enter settings for a LC method (not covered in this protocol).
51| Save the method by selecting 'File' → 'Save As…' .
run Qc samples • tIMInG ~6 h 52| Acquire data on a QC sample in 4-6 replicate LC runs.
53|
Open the QC Skyline document that was saved in Step 12.
54| Select 'File' → 'Import' → 'Results…' and click 'OK' . Select all of the raw data files from all of the QC runs by holding down the Shift key to select a range of files, and select Open. If a dialog box appears prompting about removing a common prefix, select 'Do not remove' . The data should import in 5 min or less.
55| Select 'View' → 'Peak Areas' → 'Replicate Comparison' and 'View' → 'Retention Times' → 'Replicate Comparison' to view plots of the peak area (example in Fig. 9a ) and retention time (example in Fig. 9b ) of the currently selected peptide in each QC run. Click on each peptide and verify that the retention time and peak areas for each peptide are stable (Fig. 9) . ? troublesHootInG 56| Close the peak area and retention time windows, and click 'View' → 'Auto-Zoom'→ 'Best Peak' to zoom in on the chromatogram peak for the peptide. Click 'View' → 'Transitions' → 'Split Graph' to view MS chromatograms and MS/MS chromatograms separately (example in Fig. 10 ). Select each peptide and verify that the chromatographic peak shape is acceptable, and that the mass measurement accuracy (annotated above the peak) is reasonable.
? troublesHootInG run samples • tIMInG variable 57| Acquire data on the samples to be analyzed, at least one DDA data set should be acquired for each sample type for generating a spectral library. It is recommended that QC samples be analyzed every four or five injections to monitor system performance 48 . 
59| Open the Skyline file saved in
Step 34 and click 'Settings' → 'Peptide Settings' . Click on the 'Library' tab, and select 'Build…' .
60|
Type in a name for the library, and select an Output Path in which the created library will be stored. Uncheck the 'Keep redundant library' checkbox, and enter a cutoff score of 0.99.
The 'Lab Authority' should be a unique identifier for the laboratory that generated the library (e.g., proteome. gs.washington.edu). Click 'Next' .
61|
Select 'Add Files…' and add the files generated from the database search. Select 'Finish' . A progress bar will appear on the bottom status bar of Skyline, and a notification will appear when the library generation is complete. ? troublesHootInG 62| Select the checkbox next to the library that was just built.
63|
Click on 'Explore…' and verify that the library that was just built is displayed in the Spectral Library Explorer. Verify that the spectra have retention time information, shown as 'RT: …' in the lower right portion of the window, beneath the spectrum plot. (optional) build a background proteome • tIMInG 5 min  crItIcal If there is sequence information (e.g., open reading frame sequences or ESTs for the organism being analyzed) for proteins that could be potentially present in the measured samples, a background proteome can be defined to improve data analysis in Skyline. Improvements include easier insertion of proteins into the Skyline document, automated retrieval of metadata for proteins from UniProt and the ability to inspect peptide uniqueness.
68| Click 'Settings' → 'Peptide Settings', select the 'Digestion' tab and select '<Add…>' under Background Proteome.
69|
Enter a name for the background proteome such as 'yeast', click the 'Create…' button and find a location for the background proteome to be stored.
70|
Select 'Add File…' and select a .fasta file containing the protein sequences for the organism(s) being studied. Figure 10 | Skyline DIA data:
LGEHNIDVLEGNEQFINAAK+++. The extracted precursor (top) and fragment ion (bottom) signal extracted for the peptide precursor LGEHNIDVLEGNEQFINAAK+++ from DIA data acquired on a yeast sample digest using this protocol are plotted. The vertical lines on either side of the peak indicate the integration boundaries for the peak. The vertical blue line shows the retention time of the peptide identification contained in the spectral library generated from DDA data. The mass measurement error and retention time of the most intense transition (fragment ion data) or isotopic peak (precursor data) for the peptide precursor are annotated above the chromatographic peak. 79| Click 'OK' and click 'OK' in the 'Edit Reports' dialog box.
80|
In the 'Export Report' dialog box, select the report that was just generated and click 'Export'; choose a location to save the report to, and click 'Save' to export a comma-separated-value (.csv) file that is easy to parse and that can be viewed using most spreadsheet software.
81| (Optional) Generate more advanced reports by following the tutorial at https://skyline.gs.washington.edu/labkey/tutorial_ custom_reports.url.
? troublesHootInG Troubleshooting advice can be found in table 2. • antIcIpateD results
Qc sample
The peak areas and retention times of all of the standard peptides should be reproducible by the end of the QC runs (Figs. 9 and 12), with good peak shape and stable spray (changes in ion current owing to fluctuations in electrospray ionization). The expected level of reproducibility will vary on the basis of the LC setup being used. The mass measurement error should be as expected for the instrument being used. In the QC data from Figure 9 and Figure 12 , the mass measurement error (~11 p.p.m.) is consistently worse than expected for a Q-Exactive (<10 p.p.m.), indicating that the instrument should be calibrated.
DIa data
The results of the DIA data will strongly depend on the sample being analyzed and the equipment being used to analyze the sample. In a complex mixture such as a yeast lysate, the lower limit of quantification for peptides is generally expected to be in the attomolar-to-femtomolar range. In a mixture as complex as a yeast lysate, many peptide peaks will be well-behaved (Fig. 10) , but others will require further refinement. For example, some peaks may have strong interference The extracted precursor (top) and fragment ion (bottom) signal extracted for the peptide precursor NYIIEELNVR++ from DIA data acquired on a yeast sample digest using this protocol are plotted. The vertical lines on either side of the peak indicate the integration boundaries for the peak. The vertical blue line shows the retention time of the peptide identification contained in the spectral library generated from DDA data. The mass measurement error and retention time of the most intense transition (fragment ion data) or isotopic peak of (precursor data) for the peptide precursor are annotated above the chromatographic peak.
in the precursor signal (Fig. 13) . Other peptides may additionally have strong interference in some of the transitions being measured, which should be removed from consideration before analysis (Fig. 14) . Finally, some peptides may fragment poorly, and show only a good signal from measurement of precursor ions (Fig. 15) . Note that in Figures 10 and 13-15 , up to ten fragment ions were extracted for each peptide (compared with five fragment ions in Step 66) to more strongly illustrate these behaviors. Similarly to an SRM experiment, many peptides are expected to be undetectable or have a very low measured intensity owing to factors independent of the acquisition method such as inefficient ionization by electrospray or incomplete digestion. Conversely, it is preferable to select a set of peptides that respond well in the mass spectrometer ('proteotypic') for analysis 6, 49, 50 . For each peptide, the sensitivity and accuracy of quantification can be improved by manually removing transitions with strong interference 6 . For a detailed tutorial on manual transition refinement from DIA data, we refer the reader to the 'Exploring DIA Results' section of the Skyline DIA Tutorial (https://skyline.gs.washington.edu/ labkey/tutorial_dia.url). The extracted precursor (top) and fragment ion (bottom) signal extracted for the peptide precursor TYAAEIAHNISAK++ from DIA data acquired on a yeast sample digest using this protocol are plotted. The vertical lines on either side of the peak indicate the integration boundaries for the peak. The vertical blue line shows the retention time of the peptide identification contained in the spectral library generated from DDA data. The mass measurement error and retention time of the most intense transition (fragment ion data) or isotopic peak of (precursor data) for the peptide precursor are annotated above the chromatographic peak. Figure 15 | Skyline DIA data: VSLDDLQQSIEEDEDHVQST. The extracted precursor (top) and fragment ion (bottom) signal extracted for the peptide precursor VSLDDLQQSIEEDEDHVQST+++ from DIA data acquired on a yeast sample digest using this protocol are plotted. The vertical lines on either side of the peak indicate the integration boundaries for the peak. The vertical blue line shows the retention time of the peptide identification contained in the spectral library generated from DDA data. The mass measurement error and retention time of the most intense transition (fragment ion data) or isotopic peak (precursor data) for the peptide precursor are annotated above the chromatographic peak.
